Comparative study of adefovir and pegylated interferon for chronic hepatitis B.

🔍 Seven RCTs analyzed
🧬 Adefovir more effective for LAM-resistant patients (35-85% response)
🧪 ALT normalization was common
💊 Cost/QALY: £5,994-£16,569

#HepatitisBTreatment #CostEffectiveness #Adefovir #PegylatedInterferon #QALY #Pub2Post

https://tnyp.me/cleqI1LC/m